Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Georgetown University Medical Center
392
mi
from 02139
Washington,
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Georgetown University Medical Center
392
mi
from 02139
Washington,
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Advanced Research Institute of Miami
1283
mi
from 02139
Homestead, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Advanced Research Institute of Miami
1283
mi
from 02139
Homestead, FL
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
NewPhase Clinical Trials, Corp.
1252
mi
from 02139
Miami Beach, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
NewPhase Clinical Trials, Corp.
1252
mi
from 02139
Miami Beach, FL
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Professional Health Care of Pinellas
1198
mi
from 02139
Saint Petersburg, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Professional Health Care of Pinellas
1198
mi
from 02139
Saint Petersburg, FL
Click here to add this to my saved trials
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction
Status: Enrolling
Updated:  2/27/2018
Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center
182
mi
from 02139
New York, NY
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction
Status: Enrolling
Updated: 2/27/2018
Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center
182
mi
from 02139
New York, NY
Click here to add this to my saved trials
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Status: Enrolling
Updated:  3/1/2018
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Status: Enrolling
Updated: 3/1/2018
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Mayo Clinic Scottsdale
2275
mi
from 02139
Scottsdale, AZ
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Mayo Clinic Scottsdale
2275
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Front Range Cancer Specialists
1749
mi
from 02139
Fort Collins, CO
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Front Range Cancer Specialists
1749
mi
from 02139
Fort Collins, CO
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Poudre Valley Hospital
1749
mi
from 02139
Fort Collins, CO
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Poudre Valley Hospital
1749
mi
from 02139
Fort Collins, CO
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
90
mi
from 02139
Hartford, CT
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
90
mi
from 02139
Hartford, CT
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
2252
mi
from 02139
Boise, ID
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
2252
mi
from 02139
Boise, ID
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
St. Joseph Medical Center
934
mi
from 02139
Bloomington, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
St. Joseph Medical Center
934
mi
from 02139
Bloomington, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare-Bloomington
932
mi
from 02139
Bloomington, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare-Bloomington
932
mi
from 02139
Bloomington, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Canton
985
mi
from 02139
Canton, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Canton
985
mi
from 02139
Canton, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Graham Hospital
985
mi
from 02139
Canton, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Graham Hospital
985
mi
from 02139
Canton, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Carthage
1043
mi
from 02139
Carthage, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Carthage
1043
mi
from 02139
Carthage, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Eureka
944
mi
from 02139
Eureka, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Eureka
944
mi
from 02139
Eureka, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Eureka Community Hospital
944
mi
from 02139
Eureka, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Eureka Community Hospital
944
mi
from 02139
Eureka, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Galesburg Clinic, PC
997
mi
from 02139
Galesburg, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Galesburg Clinic, PC
997
mi
from 02139
Galesburg, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Galesburg
997
mi
from 02139
Galesburg, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Galesburg
997
mi
from 02139
Galesburg, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Havana
991
mi
from 02139
Havana, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Havana
991
mi
from 02139
Havana, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Mason District Hospital
991
mi
from 02139
Havana, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Mason District Hospital
991
mi
from 02139
Havana, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Kewanee Clinic
970
mi
from 02139
Kewanee, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Kewanee Clinic
970
mi
from 02139
Kewanee, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
McDonough District Hospital
1020
mi
from 02139
Macomb, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
McDonough District Hospital
1020
mi
from 02139
Macomb, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Macomb
1020
mi
from 02139
Macomb, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Macomb
1020
mi
from 02139
Macomb, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
996
mi
from 02139
Moline, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
996
mi
from 02139
Moline, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Monmouth
1011
mi
from 02139
Monmouth, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Monmouth
1011
mi
from 02139
Monmouth, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
OSF Holy Family Medical Center
1011
mi
from 02139
Monmouth, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
OSF Holy Family Medical Center
1011
mi
from 02139
Monmouth, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Community Cancer Center
933
mi
from 02139
Normal, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Community Cancer Center
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Community Cancer Center
933
mi
from 02139
Normal, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Community Cancer Center
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
BroMenn Regional Medical Center
933
mi
from 02139
Normal, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
BroMenn Regional Medical Center
933
mi
from 02139
Normal, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
OSF Saint Elizabeth Medical Center
914
mi
from 02139
Ottawa, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
OSF Saint Elizabeth Medical Center
914
mi
from 02139
Ottawa, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Cancer Treatment Center at Pekin Hospital
965
mi
from 02139
Pekin, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Cancer Treatment Center at Pekin Hospital
965
mi
from 02139
Pekin, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Methodist Medical Center of Illinois
961
mi
from 02139
Peoria, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Methodist Medical Center of Illinois
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
OSF St. Francis Medical Center
961
mi
from 02139
Peoria, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
OSF St. Francis Medical Center
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois Valley Community Hospital
928
mi
from 02139
Peru, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois Valley Community Hospital
928
mi
from 02139
Peru, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Peru
928
mi
from 02139
Peru, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Peru
928
mi
from 02139
Peru, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Perry Memorial Hospital
944
mi
from 02139
Princeton, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Perry Memorial Hospital
944
mi
from 02139
Princeton, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Illinois CancerCare - Princeton
944
mi
from 02139
Princeton, IL
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Illinois CancerCare - Princeton
944
mi
from 02139
Princeton, IL
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
St. Francis Hospital and Health Centers - Beech Grove Campus
801
mi
from 02139
Beech Grove, IN
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
St. Francis Hospital and Health Centers - Beech Grove Campus
801
mi
from 02139
Beech Grove, IN
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Reid Hospital & Health Care Services
737
mi
from 02139
Richmond, IN
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Reid Hospital & Health Care Services
737
mi
from 02139
Richmond, IN
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Clinical Research Facility
995
mi
from 02139
Bettendorf, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Clinical Research Facility
995
mi
from 02139
Bettendorf, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Mercy Cancer Center - West Lakes
1162
mi
from 02139
Clive, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Mercy Cancer Center - West Lakes
1162
mi
from 02139
Clive, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
John Stoddard Cancer Center at Iowa Methodist Medical Center
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
John Stoddard Cancer Center at Iowa Methodist Medical Center
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Medical Oncology and Hematology Associates at Mercy Cancer Center
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Medical Oncology and Hematology Associates at Mercy Cancer Center
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
John Stoddard Cancer Center at Iowa Methodist Medical Center
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
John Stoddard Cancer Center at Iowa Methodist Medical Center
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated:  3/2/2018
Mercy Cancer Center at Mercy Medical Center - Des Moines
1154
mi
from 02139
Des Moines, IA
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Status: Enrolling
Updated: 3/2/2018
Mercy Cancer Center at Mercy Medical Center - Des Moines
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials